BioLife Sciences Inc.
BLFE
$0.00
$0.000.00%
OTC PK
| 02/28/2022 | 02/28/2021 | ||||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 15.60K | -- | |||
| Total Receivables | -- | -- | |||
| Inventory | -- | -- | |||
| Prepaid Expenses | 61.40K | -- | |||
| Finance Division Loans and Leases Current | -- | -- | |||
| Total Finance Division Other Current Assets | -- | -- | |||
| Other Current Assets | -- | -- | |||
| Total Current Assets | 77.00K | -- | |||
|
|
|||||
| Total Current Assets | 77.00K | -- | |||
| Net Property, Plant & Equipment | 98.10K | -- | |||
| Long-term Investments | -- | -- | |||
| Goodwill | -- | -- | |||
| Total Other Intangibles | 865.00K | -- | |||
| Finance Div Loans & Leases LT | -- | -- | |||
| Total Finance Div Other LT Assets | -- | -- | |||
| Total Other Assets | -- | -- | |||
| Total Assets | 1.04M | -- | |||
|
|
|||||
| Total Accounts Payable | 662.40K | -- | |||
| Total Accrued Expenses | -- | -- | |||
| Short-term Debt | 300.90K | -- | |||
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | |||
| Finance Division Debt Current | 86.40K | -- | |||
| Total Finance Division Other Current Liabilities | 89.30K | -- | |||
| Total Other Current Liabilities | 89.30K | -- | |||
| Total Current Liabilities | 1.14M | -- | |||
|
|
|||||
| Total Current Liabilities | 1.14M | -- | |||
| Long-Term Debt | -- | -- | |||
| Short-term Debt | 300.90K | -- | |||
| Capital Leases | 10.60K | -- | |||
| Finance Division Debt Non Current | -- | -- | |||
| Total Finance Division Other Non Current Liabilities | -- | -- | |||
| Total Other Liabilities | -- | -- | |||
| Total Liabilities | 1.15M | -- | |||
|
|
|||||
| Common Stock & APIC | 1.77M | -- | |||
| Retained Earnings | -1.86M | -- | |||
| Treasury Stock & Other | -18.80K | -- | |||
| Total Common Equity | -109.60K | -- | |||
|
|
|||||
| Preferred Stock Redeemable | -- | -- | |||
| Preferred Stock Non Redeemable | -- | -- | |||
| Preferred Stock Convertible | -- | -- | |||
| Preferred Stock, Others | -- | -- | |||
| Total Preferred Equity | -- | -- | |||
|
|
|||||
| Total Common Equity | -109.60K | -- | |||
| Total Preferred Equity | -- | -- | |||
| Total Minority Interest | -- | -- | |||
| Total Equity | -109.60K | -- | |||
|
|
|||||